HNHai-Yun Niu

Hai-Yun Niu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Hai-Yun Niu has a total of 9 co-authors. Here are the top co-authors by number of shared publications:

  • Bing Xu

    Department of Orthopedics, and Key Laboratory of Orthopedic Biomechanics of Hebei Province, Orthopedic Research Institution of Hebei Province, The Third Hospital of Hebei Medical University, Shijiazhuang, Hebei 050051, P.R. China

    2 shared publications
  • Guang Yang

    Department of Orthopedics, and Key Laboratory of Orthopedic Biomechanics of Hebei Province, Orthopedic Research Institution of Hebei Province, The Third Hospital of Hebei Medical University, Shijiazhuang, Hebei 050051, P.R. China

    2 shared publications
  • Han Li

    Department of Orthopedics, and Key Laboratory of Orthopedic Biomechanics of Hebei Province, Orthopedic Research Institution of Hebei Province, The Third Hospital of Hebei Medical University, Shijiazhuang, Hebei 050051, P.R. China

    2 shared publications
  • De-Cheng Shao

    Department of Orthopedics, and Key Laboratory of Orthopedic Biomechanics of Hebei Province, Orthopedic Research Institution of Hebei Province, The Third Hospital of Hebei Medical University, Shijiazhuang, Hebei 050051, P.R. China

    1 shared publication
  • De‑Cheng Shao

    Department of Orthopedics, and Key Laboratory of Orthopedic Biomechanics of Hebei Province, Orthopedic Research Institution of Hebei Province, The Third Hospital of Hebei Medical University, Shijiazhuang, Hebei 050051, P.R. China

    1 shared publication
  • Hong-Yu Meng

    Department of Orthopedics, and Key Laboratory of Orthopedic Biomechanics of Hebei Province, Orthopedic Research Institution of Hebei Province, The Third Hospital of Hebei Medical University, Shijiazhuang, Hebei 050051, P.R. China

    1 shared publication

Latest Publications

  • Open Access

    [Expression of Concern] Resveratrol improves neurological outcome and neuroinflammation following spinal cord injury through enhancing autophagy involving the AMPK/mTOR pathway

    by Hong-Yu Meng, De-Cheng Shao, Han Li, Xiao-Dan Huang, Guang Yang, Bing Xu, Hai-Yun Niu

    Following the publication of this paper, it was drawn to the Editor’s attention by a concerned reader that, regarding the confocal microscopic images shown in Fig 3, the top (Sham) and bottom (SCI) data panels appeared to show a small section of overlapping data, such that data which were intended to show the results from differently performed experiments had apparently been derived from the same original source. The authors were contacted by the Editorial Office to offer an explanation for this apparent anomaly in the presentation of the data in this paper; however, up to this time, no response from them has been forthcoming. Owing to the fact that the Editorial Office has been made aware of potential issues surrounding the scientific integrity of this paper, we are issuing an Expression of Concern to notify readers of this potential problem while the Editorial Office continues to investigate this matter further. [Molecular Medicine Reports 18: 2237‑2244, 2018; DOI: 10.3892/mmr.2018.9194]

  • Open Access

    Resveratrol improves neurological outcome and neuroinflammation following spinal cord injury through enhancing autophagy involving the AMPK/mTOR pathway

    by Hong‑Yu Meng, De‑Cheng Shao, Han Li, Xiao‑Dan Huang, Guang Yang, Bing Xu, Hai‑Yun Niu

    Resveratrol, a natural phenolic compound, provides neuroprotective effects, however, the specific mechanisms of action remain to be elucidated. The purpose of the present study was to examine the neuroprotective effect of resveratrol on spinal cord injury (SCI) and the potential molecular mechanisms of action. A rat model of SCI was induced using Allen's method, and resveratrol (100 mg/kg) was intraperitoneally injected 1 day following surgery. The recovery of neurological function was assessed using the Basso, Beattie, Bresnahan scoring system and an inclined plane test. The concentrations of pro‑ and anti‑inflammatory factors were measured using ELISA. The expression and location of autophagy markers were measured using western blot and immunofluorescence analyses. The results suggested that resveratrol administration resulted in functional improvement of locomotor activity and reduced neuroinflammation following the induction of SCI. In addition, autophagy was activated following SCI, as demonstrated by the significantly increased ratio of microtubule‑associated protein light chain 3 (LC3)‑II/LC3‑I and expression of Beclin‑1 in the injured spinal cord. Of note, the enhancement of phosphorylated (p)‑AMP‑activated protein kinase (AMPK) and the reduction of p‑mammalian target of rapamycin (mTOR) following SCI indicated that the SCI‑induced activation of autophagy was associated with the AMPK/mTOR signaling pathway. Resveratrol treatment further enhanced the activation of autophagy via the AMPK/mTOR pathway following SCI. By contrast, the autophagic inhibitor, 3‑methyladenine, partially inhibited the neuroprotective effects of resveratrol treatment. Together, these findings suggested that resveratrol promoted functional recovery and inhibited neuroinflammation through the activation of autophagy mediated by the AMPK/mTOR pathway following SCI.